Skip to content
Matica Biotechnology Manufacturing Breakthroughs
  • About
    • Who We Are
    • Leadership
  • Services
    • Cell Line and Vector Development
      • MatiMax™ Platform
    • Process Development
    • Assay Development
    • GMP Production
    • Quality
  • News & Events
    • Newsroom
    • Events
  • Resources
  • Careers
  • Contact Us
  • About
    • Who We Are
    • Leadership
  • Services
    • Cell Line and Vector Development
      • MatiMax™ Platform
    • Process Development
    • Assay Development
    • GMP Production
    • Quality
  • News & Events
    • Newsroom
    • Events
  • Resources
  • Careers
  • Contact Us

White Paper

White Paper

Analytical Development for GMP Viral Vector Production – Establishing GMP Comparability and Minimizing Variability

White Paper

Analytical Development for GMP Viral Vector Production – Case Study of AAV8 and Lentivirus

White Paper

Analytical Development for GMP Viral Vector Production – CQA (Safety and Stability)

White Paper

Analytical Development for GMP Viral Vector Production – CQA (Identity, Potency and Purity)

White Paper

Project Management in Viral Vector Manufacturing

White Paper

Advancing Biotechnology – Potential of Stable Producer Cell Line in Cell and Gene Therapy Development

White Paper

Critical Challenges and Solutions for Viral Vector Manufacturing – Supply Chain

White Paper

Critical Challenges and Solutions for Viral Vector Manufacturing – In-Process Analytics and Monitoring

White Paper

Critical Challenges and Solutions for Viral Vector Manufacturing – Scaling Process

White Paper

Critical Challenges and Solutions for Viral Vector Manufacturing – Downstream Process and Technology Transfer

Posts navigation

1 2 Next

Get in Touch

When Bringing Your Therapy to Market Is Everything,

Make it happen with Matica Bio.

Get Started

© 2025 Matica Biotechnology. All Rights Reserved.

LinkedIn
  • Site Map
  • Privacy Policy
  • Contact Us
How can we help you?